Kymera Therapeutics stock extends slide as KYMR closes down 6.5% — what investors watch next
NEW YORK, Jan 4, 2026, 11:20 ET — Market closed Kymera Therapeutics, Inc. (KYMR) shares closed down 6.5% on Friday at $72.76, extending a losing streak to seven consecutive sessions as the U.S. market heads into the first full trading week of 2026. The stock is down about 13% since Dec. 23 and roughly 29% below the record intraday high…